GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’ Read more →

Chutes & Ladders—Idorsia locks in new CEO after shakeup Read more →

Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail Read more →